Béatrice Labrosse

1.0k total citations
18 papers, 856 citations indexed

About

Béatrice Labrosse is a scholar working on Virology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Béatrice Labrosse has authored 18 papers receiving a total of 856 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Virology, 13 papers in Infectious Diseases and 7 papers in Epidemiology. Recurrent topics in Béatrice Labrosse's work include HIV Research and Treatment (14 papers), HIV/AIDS drug development and treatment (11 papers) and Immune Cell Function and Interaction (5 papers). Béatrice Labrosse is often cited by papers focused on HIV Research and Treatment (14 papers), HIV/AIDS drug development and treatment (11 papers) and Immune Cell Function and Interaction (5 papers). Béatrice Labrosse collaborates with scholars based in France, Australia and United Kingdom. Béatrice Labrosse's co-authors include Marc Alizon, François Clavel, Anne Brelot, Fabrizio Mammano, Bin Su, Nadia Naffakh, Olivier Pleskoff, Nikolaus Heveker, Dominique Schols and Erik De Clercq and has published in prestigious journals such as PLoS ONE, Journal of Virology and AIDS.

In The Last Decade

Béatrice Labrosse

18 papers receiving 834 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Béatrice Labrosse France 13 464 397 310 250 186 18 856
Julie N. Reitter United States 15 635 1.4× 341 0.9× 403 1.3× 325 1.3× 374 2.0× 24 1.1k
Wuxun Lu United States 15 212 0.5× 242 0.6× 404 1.3× 198 0.8× 490 2.6× 25 1.0k
Zachary Ende United States 10 237 0.5× 165 0.4× 238 0.8× 303 1.2× 155 0.8× 15 664
Steffen Wildum Switzerland 19 374 0.8× 339 0.9× 646 2.1× 248 1.0× 296 1.6× 34 1.2k
P L Nara United States 12 688 1.5× 321 0.8× 183 0.6× 479 1.9× 206 1.1× 15 898
Zhujun Ao Canada 20 552 1.2× 538 1.4× 280 0.9× 192 0.8× 460 2.5× 45 1.0k
Gabriella Rozera Italy 16 315 0.7× 342 0.9× 228 0.7× 80 0.3× 249 1.3× 55 786
Rukhsana Rahman United States 9 670 1.4× 508 1.3× 147 0.5× 222 0.9× 293 1.6× 20 849
Steve C. Pettit United States 18 962 2.1× 830 2.1× 186 0.6× 85 0.3× 447 2.4× 24 1.3k
P L Callahan United States 9 437 0.9× 496 1.2× 332 1.1× 116 0.5× 662 3.6× 9 1.3k

Countries citing papers authored by Béatrice Labrosse

Since Specialization
Citations

This map shows the geographic impact of Béatrice Labrosse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Béatrice Labrosse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Béatrice Labrosse more than expected).

Fields of papers citing papers by Béatrice Labrosse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Béatrice Labrosse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Béatrice Labrosse. The network helps show where Béatrice Labrosse may publish in the future.

Co-authorship network of co-authors of Béatrice Labrosse

This figure shows the co-authorship network connecting the top 25 collaborators of Béatrice Labrosse. A scholar is included among the top collaborators of Béatrice Labrosse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Béatrice Labrosse. Béatrice Labrosse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Carbonnelle, Caroline, Delphine Pannetier, Stéphane Mély, et al.. (2022). Natural History of Sudan ebolavirus to Support Medical Countermeasure Development. Vaccines. 10(6). 963–963. 11 indexed citations
2.
Taudon, Nicolas, et al.. (2013). Stability and antiviral activity against human cytomegalovirus of artemisinin derivatives. Journal of Antimicrobial Chemotherapy. 69(1). 34–40. 47 indexed citations
3.
Takeuchi, Junko S., Séverine Mercier‐Delarue, Diane Ponscarme, et al.. (2013). High level of susceptibility to human TRIM5α conferred by HIV-2 capsid sequences. Retrovirology. 10(1). 11 indexed citations
4.
Labrosse, Béatrice, Mathieu Tourdjman, Raphaël Porcher, et al.. (2010). Detection of Extensive Cross-Neutralization between Pandemic and Seasonal A/H1N1 Influenza Viruses Using a Pseudotype Neutralization Assay. PLoS ONE. 5(6). e11036–e11036. 27 indexed citations
5.
Su, Bin, Sébastien Wurtzer, Marie‐Anne Rameix‐Welti, et al.. (2009). Enhancement of the Influenza A Hemagglutinin (HA)-Mediated Cell-Cell Fusion and Virus Entry by the Viral Neuraminidase (NA). PLoS ONE. 4(12). e8495–e8495. 99 indexed citations
6.
Munier, Sandie, Thibaut Larcher, Denis Soubieux, et al.. (2009). A Genetically Engineered Waterfowl Influenza Virus with a Deletion in the Stalk of the Neuraminidase Has Increased Virulence for Chickens. Journal of Virology. 84(2). 940–952. 116 indexed citations
7.
Yu, Huifeng, Daniela Tudor, Annette Alfsen, et al.. (2008). Peptide P5 (residues 628–683), comprising the entire membrane proximal region of HIV-1 gp41 and its calcium-binding site, is a potent inhibitor of HIV-1 infection. Retrovirology. 5(1). 93–93. 11 indexed citations
8.
Nora, Tamara, Francine Bouchonnet, Béatrice Labrosse, et al.. (2008). Functional diversity of HIV-1 envelope proteins expressed by contemporaneous plasma viruses. Retrovirology. 5(1). 23–23. 7 indexed citations
9.
Goubard, Armelle, François Clavel, Fabrizio Mammano, & Béatrice Labrosse. (2008). In vivo selection by enfuvirtide of HIV type-1 env quasispecies with optimal potential for phenotypic expression of HR1 mutations. Antiviral Therapy. 14(4). 597–602. 4 indexed citations
10.
Lambelé, Marie, Béatrice Labrosse, Alain Moreau, et al.. (2006). Impact of Natural Polymorphism within the gp41 Cytoplasmic Tail of Human Immunodeficiency Virus Type 1 on the Intracellular Distribution of Envelope Glycoproteins and Viral Assembly. Journal of Virology. 81(1). 125–140. 26 indexed citations
11.
Labrosse, Béatrice, Laurence Morand‐Joubert, Armelle Goubard, et al.. (2006). Role of the Envelope Genetic Context in the Development of Enfuvirtide Resistance in Human Immunodeficiency Virus Type 1-Infected Patients. Journal of Virology. 80(17). 8807–8819. 46 indexed citations
12.
Skrabal, Katharina, Virginie Trouplin, Béatrice Labrosse, et al.. (2003). Impact of antiretroviral treatment on the tropism of HIV-1 plasma virus populations. AIDS. 17(6). 809–814. 39 indexed citations
13.
Labrosse, Béatrice, Jean‐Louis Labernardière, Elisabeth Dam, et al.. (2002). Baseline Susceptibility of Primary Human Immunodeficiency Virus Type 1 to Entry Inhibitors. Journal of Virology. 77(2). 1610–1613. 83 indexed citations
14.
Labrosse, Béatrice, et al.. (2001). Cooperation of the V1/V2 and V3 Domains of Human Immunodeficiency Virus Type 1 gp120 for Interaction with the CXCR4 Receptor. Journal of Virology. 75(12). 5457–5464. 56 indexed citations
15.
16.
Labrosse, Béatrice, Anne Brelot, Nikolaus Heveker, et al.. (1998). Determinants for Sensitivity of Human Immunodeficiency Virus Coreceptor CXCR4 to the Bicyclam AMD3100. Journal of Virology. 72(8). 6381–6388. 127 indexed citations
17.
Pleskoff, Olivier, et al.. (1997). Human immunodeficiency virus strains differ in their ability to infect CD4+ cells expressing the rat homolog of CXCR-4 (fusin). Journal of Virology. 71(4). 3259–3262. 59 indexed citations
18.
Labrosse, Béatrice, et al.. (1997). Resistance to a drug blocking human immunodeficiency virus type 1 entry (RPR103611) is conferred by mutations in gp41. Journal of Virology. 71(11). 8230–8236. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Julie N. Reitter Breakdown of academic impact, for papers by Wuxun Lu Breakdown of academic impact, for papers by Zachary Ende Breakdown of academic impact, for papers by Steffen Wildum Breakdown of academic impact, for papers by P L Nara Breakdown of academic impact, for papers by Zhujun Ao Breakdown of academic impact, for papers by Gabriella Rozera Breakdown of academic impact, for papers by Rukhsana Rahman Breakdown of academic impact, for papers by Steve C. Pettit Breakdown of academic impact, for papers by P L Callahan
Rankless by CCL
2026